Careers & Tenders
Subscribe

Glenda Gray

SA leads HIV/Aids vaccine discovery research team
Health
/ 24 January 2024

SA leads HIV/Aids vaccine discovery research team

USAID has pumped $45 million in grant funding to support the work of a consortium of top African scientists from eight countries

This content is restricted to subscribers only.

Join the M&G Community

Our commitment at the Mail & Guardian is to ensure every reader enjoys the finest experience. Join the M&G community and support us in delivering in-depth news to you consistently.

Subscription enables:

  • – M&G community membership
  • – independent journalism
  • – access to all premium articles & features
  • – a digital version of the weekly newspaper
  • – invites to subscriber-only events
  • – the opportunity to test new online features first

Already a subscriber?
.

By
Academics, students urge Wits University to divest from fossil fuels
The Green Guardian
/ 18 August 2021

Academics, students urge Wits University to divest from fossil fuels

Staff and students argue it is unethical for university to profit from an industry that damages the planet and distorts science

This content is restricted to subscribers only.

Join the M&G Community

Our commitment at the Mail & Guardian is to ensure every reader enjoys the finest experience. Join the M&G community and support us in delivering in-depth news to you consistently.

Subscription enables:

  • – M&G community membership
  • – independent journalism
  • – access to all premium articles & features
  • – a digital version of the weekly newspaper
  • – invites to subscriber-only events
  • – the opportunity to test new online features first

Already a subscriber?
.

By
How SA wants to sell the AstraZeneca vaccine for half the price and what the loss could be
Health
/ 16 February 2021

How SA wants to sell the AstraZeneca vaccine for half the price and what the loss could be

Health Minister Zweli Mkhize says selling on the vaccines will stem wasteful expenditure, but people close to the discussions with AU say they will be sold on the cheap

This content is restricted to subscribers only.

Join the M&G Community

Our commitment at the Mail & Guardian is to ensure every reader enjoys the finest experience. Join the M&G community and support us in delivering in-depth news to you consistently.

Subscription enables:

  • – M&G community membership
  • – independent journalism
  • – access to all premium articles & features
  • – a digital version of the weekly newspaper
  • – invites to subscriber-only events
  • – the opportunity to test new online features first

Already a subscriber?
.

By and
No image available
Article
/ 22 January 2008

SA HIV vaccines on brink of human testing

Researchers from the University of Cape Town have developed two test HIV vaccines — the first wholly South African-developed products to enter the human clinical-trials phase, the Herald Online reported on Tuesday. The vaccines are just months away from being assessed in human clinical trials, the report said.

By
No image available
Article
/ 14 November 2007

HIV vaccine trials in SA put on hold

All HIV vaccine trials in South Africa have been put on hold following the failure of the Phambili trial. Health Minister Manto Tshabalala-Msimang on Wednesday invited researchers who worked on the Phambili study to her office in Pretoria to explain the reasons why the vaccine trial was stopped.

By
No image available
Article
/ 22 September 2007

Promising HIV vaccine trial halted in SA

A major HIV vaccine trial in South Africa was brought to a halt on Friday after interim results from a sister trial in the United States and Australia suggested it failed to prevent HIV infection. The news came as a major blow to Aids researchers as the vaccine had been billed as the world’s most promising Aids-vaccine candidate.

By